Premenopausal Osteoporosis

Overview

Journal Endocrinol Metab Clin North Am

Publisher Elsevier

Specialty Endocrinology

Date 2017 Jan 30

PMID 28131128

Citations 15

Authors

Adi Cohen

Affiliations

Soon will be listed here.

Abstract

Most premenopausal women with low trauma fracture(s) or low bone mineral density have a secondary cause of osteoporosis or bone loss. Where possible, treatment of the underlying cause should be the focus of management. Premenopausal women with an ongoing cause of bone loss and those who have had, or continue to have, low trauma fractures may require pharmacologic intervention. Clinical trials provide evidence of benefits of bisphosphonates and teriparatide for bone mineral density in several types of premenopausal osteoporosis, but studies are small and do not provide evidence regarding fracture risk reduction.

Citing Articles

Osteoporosis in axial radiographic spondyloarthritis: diagnostic limitations of bone mineral density and the need for comprehensive fracture risk assessment.

Zuchowski P, Dura M, Jeka D, Wojciechowski R, Bierwagen M, Kulakowski M Reumatologia. 2025; 62(6):466-474.

PMID: 39866305 PMC: 11758111. DOI: 10.5114/reum/194107.

Fracture risk in linear morphea-affected limbs: A pilot retrospective study of adult patients.

Kazmi M, Shaw K, Fan W, Obiakor B, Vleugels R, Haemel A JAAD Int. 2024; 18:27-29.

PMID: 39582805 PMC: 11585827. DOI: 10.1016/j.jdin.2024.08.019.

Modern approach to bone comorbidity in prolactinoma.

Uygur M, Menotti S, Santoro S, Giustina A Pituitary. 2024; 27(6):802-812.

PMID: 39541075 DOI: 10.1007/s11102-024-01469-x.

Epigenetic Aging and Musculoskeletal Outcomes in a Cohort of Women Living With HIV.

Shiau S, Zumpano F, Wang Z, Shah J, Tien P, Ross R J Infect Dis. 2024; 229(6):1803-1811.

PMID: 38366369 PMC: 11175700. DOI: 10.1093/infdis/jiae016.

Assessment of osteoporosis knowledge, awareness, and risk factors among premenopausal and postmenopausal women from Jordan: a cross-sectional study.

Khurmah M, Alkhatatbeh M, Alshogran O Arch Osteoporos. 2023; 18(1):121.

PMID: 37723412 DOI: 10.1007/s11657-023-01332-9.

References

Scholes D, LaCroix A, Ichikawa L, Barlow W, Ott S . Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception. Arch Pediatr Adolesc Med. 2005; 159(2):139-44. DOI: 10.1001/archpedi.159.2.139. View

Okada Y, Nawata M, Nakayamada S, Saito K, Tanaka Y . Alendronate protects premenopausal women from bone loss and fracture associated with high-dose glucocorticoid therapy. J Rheumatol. 2008; 35(11):2249-54. DOI: 10.3899/jrheum.080168. View

Scholes D, Ichikawa L, LaCroix A, Spangler L, Beasley J, Reed S . Oral contraceptive use and bone density in adolescent and young adult women. Contraception. 2009; 81(1):35-40. PMC: 2822656. DOI: 10.1016/j.contraception.2009.07.001. View

Bonjour J, Theintz G, Buchs B, Slosman D, Rizzoli R . Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab. 1991; 73(3):555-63. DOI: 10.1210/jcem-73-3-555. View

Nakayamada S, Okada Y, Saito K, Tanaka Y . Etidronate prevents high dose glucocorticoid induced bone loss in premenopausal individuals with systemic autoimmune diseases. J Rheumatol. 2004; 31(1):163-6. View

Finkelstein J, ARNOLD A . Increases in bone mineral density after discontinuation of daily human parathyroid hormone and gonadotropin-releasing hormone analog administration in women with endometriosis. J Clin Endocrinol Metab. 1999; 84(4):1214-9. DOI: 10.1210/jcem.84.4.5643. View

Laskey M, Prentice A . Bone mineral changes during and after lactation. Obstet Gynecol. 1999; 94(4):608-15. DOI: 10.1016/s0029-7844(99)00369-5. View

Ciacci C, Maurelli L, Klain M, Savino G, Salvatore M, Mazzacca G . Effects of dietary treatment on bone mineral density in adults with celiac disease: factors predicting response. Am J Gastroenterol. 1997; 92(6):992-6. View

Nzeusseu Toukap A, Depresseux G, Devogelaer J, Houssiau F . Oral pamidronate prevents high-dose glucocorticoid-induced lumbar spine bone loss in premenopausal connective tissue disease (mainly lupus) patients. Lupus. 2005; 14(7):517-20. DOI: 10.1191/0961203305lu2149oa. View

10.

Wu F, Mason B, Horne A, Ames R, Clearwater J, Liu M . Fractures between the ages of 20 and 50 years increase women's risk of subsequent fractures. Arch Intern Med. 2002; 162(1):33-6. DOI: 10.1001/archinte.162.1.33. View

11.

Langdahl B, Marin F, Shane E, Dobnig H, Zanchetta J, Maricic M . Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status. Osteoporos Int. 2009; 20(12):2095-104. DOI: 10.1007/s00198-009-0917-y. View

12.

Blanch J, Pacifici R, Chines A . Pregnancy-associated osteoporosis: report of two cases with long-term bone density follow-up. Br J Rheumatol. 1994; 33(3):269-72. DOI: 10.1093/rheumatology/33.3.269. View

13.

Rosenthal D, Mayo-Smith W, Hayes C, Khurana J, Biller B, Neer R . Age and bone mass in premenopausal women. J Bone Miner Res. 1989; 4(4):533-8. DOI: 10.1002/jbmr.5650040412. View

14.

Golden N, Iglesias E, Jacobson M, Carey D, Meyer W, Schebendach J . Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2005; 90(6):3179-85. DOI: 10.1210/jc.2004-1659. View

15.

Adachi J, Bensen W, Brown J, Hanley D, Hodsman A, Josse R . Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med. 1997; 337(6):382-7. DOI: 10.1056/NEJM199708073370603. View

16.

Hui S, Slemenda C, JOHNSTON Jr C . Age and bone mass as predictors of fracture in a prospective study. J Clin Invest. 1988; 81(6):1804-9. PMC: 442628. DOI: 10.1172/JCI113523. View

17.

Lopez L, Grimes D, Schulz K, Curtis K . Steroidal contraceptives: effect on bone fractures in women. Cochrane Database Syst Rev. 2006; (4):CD006033. DOI: 10.1002/14651858.CD006033.pub2. View

18.

Ross A, Manson J, Abrams S, Aloia J, Brannon P, Clinton S . The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2010; 96(1):53-8. PMC: 3046611. DOI: 10.1210/jc.2010-2704. View

19.

Nguyen T, Maynard L, Towne B, Roche A, Wisemandle W, Li J . Sex differences in bone mass acquisition during growth: the Fels Longitudinal Study. J Clin Densitom. 2001; 4(2):147-57. DOI: 10.1385/jcd:4:2:147. View

20.

Lauder T, Dixit S, Pezzin L, Williams M, Campbell C, DAVIS G . The relation between stress fractures and bone mineral density: evidence from active-duty Army women. Arch Phys Med Rehabil. 2000; 81(1):73-9. DOI: 10.1016/s0003-9993(00)90225-9. View